Why Biotech Stocks Matter
Time to Lock in Gains on this Coronavirus Cure
Can you protect yourself against the coronavirus by taking cold showers twice a day?
According to one snake oil salesman, you can.
I’m not going to give you his name because I don’t want him to get any further attention. But this self-proclaimed “healer,” recently took to Reddit to share his “research.”
It was complete horseshit.
While there are certainly some fascinating studies on how cold showers and even ice swimming could potentially strengthen your immune system, telling folks to take cold showers in an effort to avoid the coronavirus is absurd.
And I’ll be honest, too…
I’m a big fan of utilizing natural remedies, plant-based medicines, regular exercise, and a clean diet to stay healthy.
I do CrossFit at least five days a week.
Nearly all of my food is grown organically at a farm just one mile from my house.
I avoid alcohol, consume plenty of fermented foods and drinks to support a healthy gut microbiome, and practice meditation nearly every day in an effort to relieve stress and clear my head.
But this doesn’t mean I’m opposed to using conventional, Western medicine when it’s necessary.
Certainly, I opted for general anesthesia instead of a meditation session when I got my appendix removed. And I’m pretty sure the antibiotics I was given after that surgery were far more important to my overall health than the temperature of my showers.
Point is, while it’s probably not the best idea to eat unhealthy food and live a sedentary lifestyle, no matter how healthy you are, at some point in your life, you’re going to need access to modern medicine, which oftentimes relies upon developments and breakthroughs in biotechnology.
Getting Rich on Biotechs
There’s no denying that the coronavirus has wreaked havoc on the world.
Markets are crashing, panic has taken hold, and according to the Center for Infectious Disease Research and Policy, about 2.3% of those who have been infected have died. And there will be more.
So as you can imagine, I feel quite confident in saying that cold showers aren’t going to stop this thing.
Truth is, the only way that the global community will be able to battle this pandemic is with the help of the biotech community.
As reported in Reason, biotech companies are racing to develop a vaccine against the coronavirus while others are testing their currently available antiviral treatments to see if they can improve the symptoms of infected people:
The biotech company Moderna (NASDAQ: MRNA) developed its vaccine against Covid-19 just 42 days after the company received the genetic sequence information on the coronavirus. The company has already delivered that vaccine to the National Institutes of Health for human trials whose results should be known by the end of April.
Our analysts have traveled the world over, dedicated to finding the best and most profitable investments in the global energy markets. All you have to do to join our Energy and Capital investment community is sign up for the daily newsletter below.
In the meantime, here’s how the stock has performed over the past week:
Yes, while we rely on the biotech community to keep us safe from things like the coronavirus, investors also rely on it for huge gains.
More Gains Coming
I’m certainly not trying to trivialize the seriousness of the coronavirus, but to deny that you can make a ton of money by getting in on the right biotech stocks at the right time would be foolish.
In fact, I recently had a conversation about this with my good friend Jason Stutman, who’s an expert in biotech investing.
Jason has a pretty impressive track record of identifying under-the-radar biotech stocks that are on the verge of breaking out. He’s actually the one who alerted me to Moderna about two weeks ago.
He also alerted me to about a half-dozen other big winners in the biotech space (all triple-digit gains), which you can take a look at for yourself, right here.
I don’t actually fully understand how he finds these things or how his system works. It’s a bit too technical for me. But I don’t need to understand his quantitative finance modeling systems to know that if I just buy these biotech plays when he tells me to, I make a ton of cash.
It’s pretty easy, actually. But don’t take my word for it.
To a new way of life and a new generation of wealth...
@JeffSiegel on Twitter
Jeff is the founder and managing editor of Green Chip Stocks, a private investment community that capitalizes on opportunities in alternative energy, organic food markets, legal cannabis, and socially responsible investing. He has been a featured guest on Fox, CNBC, and Bloomberg Asia, and is the author of the best-selling book, Investing in Renewable Energy: Making Money on Green Chip Stocks. For more on Jeff, go to his editor's page.
Energy Demand will Increase 58% Over the Next 25 Years
After getting your report, you’ll begin receiving the Energy and Capital e-Letter, delivered to your inbox daily.